TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17624483

Group type: EXPERIMENTAL
Intervention: Exercise programme provided by public health nurses, comprising a weekly exercise class of 2 hours for 17 weeks, supplemented by daily home exercises
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 268
Study: 15112866

Group type: EXPERIMENTAL
Intervention: ReN1869 25 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ReN1869 50 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ReN1869 (subchronic mode, one week treatment)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11532537

Group type: EXPERIMENTAL
Intervention: Infrathreshold stimulation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Suprathreshold stimulation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 10 Hz stimulation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation
Number of subjects: 23
Study: 9510448

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 8
Study: 8293847

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Copper TCu 380Ag IUD
Number of subjects: 0
Study: 2735337

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g four times per day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (one tablet four times per day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ranitidine (150 mg three times per day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g four times per day) plus Ranitidine (150 mg three times per day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo plus Ranitidine (150 mg three times per day)
Number of subjects: 16
Study: 29023359

Group type: EXPERIMENTAL
Intervention: Low EA (23.4-34.1 kcal·kg ffm·d), n = 11
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Moderate EA (34.9-40.7 kcal·kg ffm·d), n = 12
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High EA (41.2-50.1 kcal·kg ffm·d), n = 12
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Generalized linear mixed-effects model
Number of subjects: 35
Study: 27398697

Group type: EXPERIMENTAL
Intervention: Intensive Behavior Education Program (IBEP)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Routine GDM management
Number of subjects: 101
Study: 24715602

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (VP) 8% gel
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 22978357

Group type: EXPERIMENTAL
Intervention: Working memory training (Cogmed RM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Math training (Academy of Math)
Number of subjects: 60
Study: 20521327

Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 18288528

Group type: EXPERIMENTAL
Intervention: Flank approach (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sub-mesocolic approach (group B)
Number of subjects: 50
Study: 15066608

Group type: EXPERIMENTAL
Intervention: High-fiber (13.5 g/d) wheat bran fiber cereal supplement
Number of subjects: 685

Group type: COMPARATOR
Intervention: Low-fiber (2.0 g/d) wheat bran fiber cereal supplement
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Both treatment groups combined
Number of subjects: 685
Study: 11495405

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine with epinephrine solution
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination buffered lidocaine with epinephrine plus hyaluronidase solution
Number of subjects: 30
Study: 9727279

Group type: EXPERIMENTAL
Intervention: Cytokine levels in asthmatics (IL-6, TNF-alpha)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cytokine levels in controls (IL-6, TNF-alpha)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Interferon-gamma levels in both groups
Number of subjects: 32
Study: 7983113

Group type: EXPERIMENTAL
Intervention: Internal fixation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 3
Study: 2648144

Group type: EXPERIMENTAL
Intervention: Tranexamic acid mouthwash (10 ml of a 4.8 percent aqueous solution)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 39
Study: 31570881

Group type: EXPERIMENTAL
Intervention: Targeted therapies
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Colorectal cancer immunotherapy
Number of subjects: 215
Study: 28320421

Group type: EXPERIMENTAL
Intervention: Usual care and patient education (7 individual sessions focusing on pain behavior and pain coping managed by a physiotherapist)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care (operation and standard rehabilitation)
Number of subjects: 56
Study: 26162244

Group type: EXPERIMENTAL
Intervention: Canadian Diabetes Risk Assessment Questionnaire (CANRISK) in women <40 years old
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Canadian Diabetes Risk Assessment Questionnaire (CANRISK) in women >40 years old
Number of subjects: 74
Study: 23254274

Group type: EXPERIMENTAL
Intervention: R+A training
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: WBV training
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 72
Study: 21616946

Group type: EXPERIMENTAL
Intervention: Acamprosate (2 g/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 56
Study: 19793858

Group type: EXPERIMENTAL
Intervention: High-Protein (HP) diet
Number of subjects: 180

Group type: COMPARATOR
Intervention: High-Carbohydrate (HC) diet
Number of subjects: 180
Study: 17046117

Group type: EXPERIMENTAL
Intervention: Altissimi and Mancini technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gale technique
Number of subjects: 20
Study: 12723677

Group type: EXPERIMENTAL
Intervention: Experimental group (received instruction on lower limb position and auditory cues)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (received no instruction)
Number of subjects: 61
Study: 10792154

Group type: EXPERIMENTAL
Intervention: Controlled-release oxybutynin tablets (10 mg once daily)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional oxybutynin tablets (5 mg twice daily)
Number of subjects: 130
Study: 9054629

Group type: EXPERIMENTAL
Intervention: 5 x RDI VITE supplement (provided in cereal)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 x RDI VITE supplement (provided in capsules)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: VITE-supplemented group
Number of subjects: 60
Study: 8311570

Group type: EXPERIMENTAL
Intervention: Single oral 6 mg/kg dose of DEC
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single oral 6 mg/kg dose of DEC preceded by 1 mg/kg DEC primer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single oral 220 micrograms/kg dose of ivermectin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single oral 200 micrograms/kg dose of ivermectin preceded by a 20 micrograms/kg ivermectin primer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single oral 400 micrograms/kg dose of ivermectin preceded by a 20 micrograms/kg ivermectin primer
Number of subjects: 50
Study: 3085896

Group type: EXPERIMENTAL
Intervention: 1 g elemental calcium plus 400 U Vitamin D
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 31999839

Group type: EXPERIMENTAL
Intervention: Dasatinib 100 mg daily
Number of subjects: 149
Study: 29032638

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26951136

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg bid per os for 3 days starting the day before biopsy
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Meropenem 1 g intravenously 1 hour prior to the procedure
Number of subjects: 110
Study: 24681657

Group type: EXPERIMENTAL
Intervention: Discontinuation of ACEIs and ARBs on the day of surgery
Number of subjects: 644

Group type: COMPARATOR
Intervention: Continuation of ACEIs and ARBs on the day of surgery
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Discontinuation of ACEIs and ARBs
Number of subjects: 644

Group type: COMPARATOR
Intervention: Continuation of ACEIs and ARBs
Number of subjects: 644
Study: 22691900

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) 20 mg (weeks 1-4), 40 mg (weeks 5-8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan potassium (LOS) 50 mg (weeks 1-4), 100 mg (weeks 5-8)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan potassium (LOS)
Number of subjects: 0
Study: 18385188

Group type: EXPERIMENTAL
Intervention: Headgear
Number of subjects: 82
Study: 18535277

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced transcranial Doppler during normal breathing in recumbent position
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced transcranial Doppler during normal breathing in standing position
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced transcranial Doppler after Valsalva maneuver in recumbent position
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced transcranial Doppler after Valsalva maneuver in standing position
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Postural dependency of right to left shunt
Number of subjects: 109
Study: 15246631

Group type: EXPERIMENTAL
Intervention: HPV11 L1 VLP vaccine (10 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV11 L1 VLP vaccine (20 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV11 L1 VLP vaccine (50 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV11 L1 VLP vaccine (100 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV16 L1 VLP vaccine (10 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV16 L1 VLP vaccine (40 microg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV16 L1 VLP vaccine (80 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11157430

Group type: EXPERIMENTAL
Intervention: Case management
Number of subjects: 708

Group type: COMPARATOR
Intervention: Control group (British Whites)
Number of subjects: 708
Study: 9304946

Group type: EXPERIMENTAL
Intervention: Enteroclysis therapy
Number of subjects: 300
Study: 8392360

Group type: EXPERIMENTAL
Intervention: Terbutaline 7.5 mg, administered twice daily for 1 week
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg, administered twice daily for 1 week
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3511328

Group type: EXPERIMENTAL
Intervention: Bubble oxygenator
Number of subjects: 91

Group type: COMPARATOR
Intervention: Bubble oxygenator with methylprednisolone sodium succinate (30 mg/kg)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Membrane oxygenator
Number of subjects: 91
Study: 28558709

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfers
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 27156829

Group type: EXPERIMENTAL
Intervention: Early discharge (within 48 to 56 hours)
Number of subjects: 769

Group type: COMPARATOR
Intervention: Standard discharge (longer than 56 hours)
Number of subjects: 769

Group type: EXPERIMENTAL
Intervention: Early discharge
Number of subjects: 769

Group type: COMPARATOR
Intervention: Standard discharge
Number of subjects: 769
Study: 25059500

Group type: EXPERIMENTAL
Intervention: Sit-stand workstation (Ergotron Workfit S) for four weeks
Number of subjects: 42
Study: 21887679

Group type: EXPERIMENTAL
Intervention: Ezatiostat
Number of subjects: 89
Study: 19150417

Group type: EXPERIMENTAL
Intervention: Single breath measurement (TLCSB)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Rebreathe helium dilution (TLCRB)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Plethysmographic lung volume (TLCpleth)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 55
Study: 17477082

Group type: EXPERIMENTAL
Intervention: Six-month ambulatory cardiac rehabilitation program (45-minute training with cycle ergometer, three times a week, and generally improving gym exercises, two times a week)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (39 normotensive patients with coronary artery disease, mean age: 59.4 ± 1.3 years)
Number of subjects: 103
Study: 15362143

Group type: EXPERIMENTAL
Intervention: In-home nursing intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: Agency nursing care or no nursing care (Control)
Number of subjects: 240
Study: 10803866

Group type: EXPERIMENTAL
Intervention: MICA allele A9
Number of subjects: 162
Study: 9297379

Group type: EXPERIMENTAL
Intervention: Cisatracurium (3 x ED95)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cisatracurium (5 x ED95)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Vecuronium (3 x ED90)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 62
Study: 8153718

Group type: EXPERIMENTAL
Intervention: Subcutaneous adrenaline
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol
Number of subjects: 71

Group type: COMPARATOR
Intervention: Intravenous aminophylline
Number of subjects: 71
Study: 3763651

Group type: EXPERIMENTAL
Intervention: Flupenthixol (0.5 mg for the first week, then doubled for 3 weeks)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Diazepam (2.5 mg for the first week, then doubled for 3 weeks)
Number of subjects: 192
Study: 28918543

Group type: EXPERIMENTAL
Intervention: DHA-supplemented diet
Number of subjects: 2

Group type: COMPARATOR
Intervention: DHA-free diet (control)
Number of subjects: 2
Study: 28464804

Group type: EXPERIMENTAL
Intervention: LEACH program (LP)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 248
Study: 26244932

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obese controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Germ-free mice colonized with stools from patients
Number of subjects: 0
Study: 24565296

Group type: EXPERIMENTAL
Intervention: Propofol via patient‐controlled analgesia device (400 μg.kg(‐1), 5‐minute lockout interval, no basal infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline infusion using the same settings as Group P
Number of subjects: 60
Study: 20857188

Group type: EXPERIMENTAL
Intervention: Coping improvement group intervention (n = 104)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Interpersonal support group intervention (n = 105)
Number of subjects: 295

Group type: COMPARATOR
Intervention: ITUR control condition (n = 86)
Number of subjects: 295
Study: 19004308

Group type: EXPERIMENTAL
Intervention: Low Intensity Laser Therapy (LILT) - Infrared laser (780 nm, 70 mw, 60s, 105J/cm2), applied twice per week for a total of eight sessions
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo laser treatment
Number of subjects: 14
Study: 16800167

Group type: EXPERIMENTAL
Intervention: Dietary intervention (normal foods)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 75
Study: 12699951

Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 100

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 100
Study: 10723834

Group type: EXPERIMENTAL
Intervention: Post-treatment self-efficacy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cognitive functioning
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Level of alcohol dependence
Number of subjects: 60
Study: 9371207

Group type: EXPERIMENTAL
Intervention: Inhaled frusemide (40 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 11
Study: 1532198

Group type: EXPERIMENTAL
Intervention: Cl2MDP (300 mg IV for 7 days, then 200 mg IM for 14 days)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cl2MDP (1,200 mg/d orally) plus chemotherapy (group B)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Chemotherapy alone (group A)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cl2MDP treatment in osteoblastic metastases
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cl2MDP overall effectiveness
Number of subjects: 76
Study: 31961975

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30656453

Group type: EXPERIMENTAL
Intervention: 3D laparoscopic TME
Number of subjects: 88

Group type: COMPARATOR
Intervention: 2D laparoscopic TME
Number of subjects: 88
Study: 28503761

Group type: EXPERIMENTAL
Intervention: Women with self-reported past gestational diabetes mellitus (pGDM)
Number of subjects: 2786

Group type: COMPARATOR
Intervention: Women without self-reported past gestational diabetes mellitus (pGDM)
Number of subjects: 2786

Group type: EXPERIMENTAL
Intervention: Women with pGDM aged <40 years
Number of subjects: 2786

Group type: COMPARATOR
Intervention: Women without pGDM aged <40 years
Number of subjects: 2786
Study: 27412548

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 90
Study: 24657491

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 45
Study: 22926182

Group type: EXPERIMENTAL
Intervention: Cobedding
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 67
Study: 19329235

Group type: EXPERIMENTAL
Intervention: Mobile bearing total knee prosthesis at 8 months postoperatively
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile bearing total knee prosthesis at 3 years postoperatively
Number of subjects: 0
Study: 18617099

Group type: EXPERIMENTAL
Intervention: Mini-implants as anchor units (G1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional methods of anchorage (G2)
Number of subjects: 40
Study: 16021535

Group type: EXPERIMENTAL
Intervention: Nomogram predictions
Number of subjects: 33

Group type: COMPARATOR
Intervention: Clinical expert predictions
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nomogram results impact on surgical planning
Number of subjects: 33
Study: 11876261

Group type: EXPERIMENTAL
Intervention: Plant sterol esters (PSE) at a dosage of 3.6 g/d in salad dressings (ranch or Italian) for 3 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control diet (salad dressings without PSE)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Plant sterol esters (PSE)
Number of subjects: 53
Study: 9918342

Group type: EXPERIMENTAL
Intervention: Tolcapone (200 mg three times daily)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Bromocriptine (titrated from 1.25 mg once daily to a mean final dose of 22.4 mg/day)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Tolcapone
Number of subjects: 146
Study: 7554756

Group type: EXPERIMENTAL
Intervention: Dobutamine infusion (15 micrograms min‐1 kg‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise (50 W)
Number of subjects: 10
Study: 1971503

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha), 35 x 10(6) units per day subcutaneously for at least 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo, 35 x 10(6) units per day subcutaneously for at least 12 weeks
Number of subjects: 34
Study: 6101676

Group type: EXPERIMENTAL
Intervention: 2 mg of intravaginal purified porcine relaxin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 30
Study: 31200830

Group type: EXPERIMENTAL
Intervention: Cisplatin added to single-agent chemotherapy
Number of subjects: 531

Group type: COMPARATOR
Intervention: Single-agent chemotherapy without cisplatin
Number of subjects: 531
Study: 27743290

Group type: EXPERIMENTAL
Intervention: Calcium ionophore A23187 alone (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium ionophore A23187 + recombinant human GM‐CSF (group B)
Number of subjects: 0
Study: 25802471

Group type: EXPERIMENTAL
Intervention: Metformin + GIMM (GI microbiome modulator)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metformin + Placebo
Number of subjects: 10
Study: 23981773

Group type: EXPERIMENTAL
Intervention: Vitamin D 5,000 IU daily
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Vitamin D 10,000 IU daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 21356647

Group type: EXPERIMENTAL
Intervention: Simultaneous stage‐matched exercise and diet (SSED) intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 19841999

Group type: EXPERIMENTAL
Intervention: Undocumented Latinos
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Undocumented status
Number of subjects: 4013
Study: 17693219

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15153841

Group type: EXPERIMENTAL
Intervention: VEGF measured in cerebrospinal fluid (CSF) using solid-phase ELISA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recoverin measured in serum using immunoenzymetric assay
Number of subjects: 0
Study: 11310932

Group type: EXPERIMENTAL
Intervention: Red Bull drink
Number of subjects: 13

Group type: COMPARATOR
Intervention: Caffeine drink
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 13
Study: 9385748

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitreoretinal surgical techniques
Number of subjects: 0
Study: 7961322

Group type: EXPERIMENTAL
Intervention: Minimal-contact intervention with counseling and mailed urine cotinine test results and self-help manual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving counseling on health effects of passive smoking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0
Study: 3322569

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg once daily
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77